Literature DB >> 22373549

Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.

Min-hang Zhou1, Li Gao, Yu Jing, Yuan-yuan Xu, Yi Ding, Nan Wang, Wei Wang, Mian-yang Li, Xiao-ping Han, Jun-zhong Sun, Li-li Wang, Li Yu.   

Abstract

ETV6 is an important hematopoietic regulatory factor and ETV6 gene rearrangement is involved in a wide variety of hematological malignancies. In this study, we sought to investigate the incidence of ETV6-associated fusion genes in B- and T-lineage acute lymphoblastic leukemia (ALL) by multiplex-nested reverse transcription-polymerase chain reaction (RT-PCR) in 176 adult ALL patients. Total RNA was extracted from bone marrow samples of ALL patients including 136 B- and 40 T-lineage ALL, and ETV6 fusion genes were detected by multiplex-nested RT-PCR. Changes of ETV6 fusion gene mRNA transcript levels were examined by real-time RT-PCR. We detected a total of 15 ETV6 gene rearrangements with a positive rate of 8.5%, involving seven ETV6-associated fusion genes in 13 B-ALL (13/136, 9.6%) and 2 T-ALL patients (2/40, 5.0%). ETV6-RUNX1 were observed in six cases (3.4%), ETV6-JAK2 in three cases (1.7%), ETV6-ABL1 in two cases (1.1%), and ETV6-ABL2, ETV6-NCOA2, ETV6-SYK, and PAX5-ETV6 each in one case (0.6%). ETV6-JAK2 was found in both B-ALL and T-ALL patients. Furthermore, real-time quantitative RT-PCR assays showed that the ETV6-RUNX1 mRNA transcript levels decreased during conventional chemotherapy or hematopoietic stem cell transplantation. This study shows that multiplex-nested RT-PCR is an effective and accurate tool to identify ETV6 rearrangements in adult ALL, which provides some clues into the diagnosis and prognosis of ALL but also molecular markers for the detection of minimal residual disease in adult ALL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22373549     DOI: 10.1007/s00277-012-1431-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  10 in total

1.  Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.

Authors:  Min-Shu Hsieh; Yueh-Hung Chou; Shin-Joe Yeh; Yih-Leong Chang
Journal:  Virchows Arch       Date:  2015-05-15       Impact factor: 4.064

2.  Modeling ETV6-JAK2-induced leukemia: insights from the zebrafish.

Authors:  Jurg Schwaller
Journal:  Haematologica       Date:  2012-12       Impact factor: 9.941

3.  Characterization of leukemias with ETV6-ABL1 fusion.

Authors:  Marketa Zaliova; Anthony V Moorman; Giovanni Cazzaniga; Martin Stanulla; Richard C Harvey; Kathryn G Roberts; Sue L Heatley; Mignon L Loh; Marina Konopleva; I-Ming Chen; Olga Zimmermannova; Claire Schwab; Owen Smith; Marie-Joelle Mozziconacci; Christian Chabannon; Myungshin Kim; J H Frederik Falkenburg; Alice Norton; Karen Marshall; Oskar A Haas; Julia Starkova; Jan Stuchly; Stephen P Hunger; Deborah White; Charles G Mullighan; Cheryl L Willman; Jan Stary; Jan Trka; Jan Zuna
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

4.  Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review.

Authors:  Katya Gancheva; Andres Virchis; Julie Howard-Reeves; Nick Cp Cross; Diana Brazma; Colin Grace; Paul Kotzampaltiris; Fedra Partheniou; Elisabeth Nacheva
Journal:  Mol Cytogenet       Date:  2013-09-20       Impact factor: 2.009

5.  Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.

Authors:  Leon Juvenal Hajingabo; Sarah Daakour; Maud Martin; Reinhard Grausenburger; Renate Panzer-Grümayer; Franck Dequiedt; Nicolas Simonis; Jean-Claude Twizere
Journal:  Mol Biol Cell       Date:  2014-10-01       Impact factor: 4.138

6.  An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL.

Authors:  Purvi M Kakadia; Ralf Schmidmaier; Andreas Völkl; Irene Schneider; Natalia Huk; Stephanie Schneider; Gerda Panzner; Ulrike Neidel; Barbara Fritz; Karsten Spiekermann; Stefan K Bohlander
Journal:  Leuk Res Rep       Date:  2016-10-14

7.  Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia.

Authors:  Xin-Yue Zhang; Hai-Ping Dai; Zheng Li; Jia Yin; Xing-Ping Lang; Chun-Xiao Yang; Sheng Xiao; Ming-Qing Zhu; Dan-Dan Liu; Hong Liu; Hong-Jie Shen; De-Pei Wu; Xiao-Wen Tang
Journal:  Front Oncol       Date:  2021-01-11       Impact factor: 6.244

8.  Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.

Authors:  Sarah Daakour; Leon Juvenal Hajingabo; Despoina Kerselidou; Aurelie Devresse; Richard Kettmann; Nicolas Simonis; Franck Dequiedt; Jean-Claude Twizere
Journal:  BMC Cancer       Date:  2016-05-26       Impact factor: 4.430

9.  A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.

Authors:  Carlos A Tirado; Ken Siangchin; David S Shabsovich; Maryam Sharifian; Gary Schiller
Journal:  Biomark Res       Date:  2016-08-25

10.  [Acute myeloid leukemia with co-expression of TEL-ABL1 and NUP98-HOXA9 fusion genes: a case report and literature review].

Authors:  C Y Wu; Y L Li; X Y Dong; L Zhang; B J Shang; W Li; Z B Li; L Zhang; Z M Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.